Armin Scherhag

Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

Tilman B. Drüeke, Francesco Locatelli, Naomi Clyne et al. · New England Journal of Medicine · 2006 · 2.1K citations · Full text

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Philip A. Poole‐Wilson, Karl Swedberg, John G.F. Cleland et al. · The Lancet · 2003 · 1.9K citations

Heart Failure, Chronic Heart Failure, Cardiovascular Disease +9

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Marco Metra, Christian Torp‐Pedersen, Karl Swedberg et al. · European Heart Journal · 2005 · 179 citations · Full text

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Christian Torp‐Pedersen, Marco Metra, Andrew Charlesworth et al. · Heart · 2007 · 173 citations · Full text

The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)

Willem J. Remme, G. Riegger, Per Hildebrandt et al. · Cardiovascular Drugs and Therapy · 2004 · 153 citations

Heart Failure, Early Combination Treatment, Structural Heart Disease +9